| Joslyn Nell Jensen, FNP-C | |
|
1034 Hughes St, Centerville, UT 84014-1656 | |
| (801) 725-5805 | |
| Not Available |
| Full Name | Joslyn Nell Jensen |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Location | 1034 Hughes St, Centerville, Utah |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1619677945 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363L00000X | Nurse Practitioner | 5645287-4405 (Utah) | Primary |
| Entity Name | Carefirst Urgent Care Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013527845 PECOS PAC ID: 3779901939 Enrollment ID: O20200921001170 |
News Archive
A UCLA research team has found a combination of proteins that could significantly improve clinical bone restoration. The findings may be a big step toward developing effective therapeutic treatments for bone skeletal defects, bone loss and osteoporosis.
Study shows prolonged stress sparks ER to release calcium stores and induce cell death in aging-related diseases such as atherosclerosis, diabetes and neurodegeneration
It should be possible to use therapeutic vaccines to create both cheap and effective drugs for diseases like cancer and allergies. One problem in developing such vaccines has previously been the lack of adjuvants, substances that make vaccines more effective. However, there has now been a major breakthrough in this area. The study, led by Swedish scientists at Uppsala University, is published in the December issue of the journal Vaccine.
A physician and researcher at the Sainte Justine University Hospital Center (Sainte-Justine UHC), a University of Montreal affiliate, saved the life of a child and, by doing so, became the first to find a new use for a drug in the fight against deadly E. coli bacteria.
Existing practice surrounding many cardiovascular medications, including anti-hypertensive and lipid-lowering agents, is based on the evaluation of response to therapy. In cases where ideal therapeutic targets (which have been identified through several previous studies) are not met in the single individual, there is evidence to support the need to intensify standard treatment so as to achieve better control of the cardiovascular risk factor under treatment (e.g. blood pressure or cholesterol levels) as this translates into a better outcome.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Joslyn Nell Jensen, FNP-C 1034 Hughes St, Centerville, UT 84014-1656 Ph: () - | Joslyn Nell Jensen, FNP-C 1034 Hughes St, Centerville, UT 84014-1656 Ph: (801) 725-5805 |
News Archive
A UCLA research team has found a combination of proteins that could significantly improve clinical bone restoration. The findings may be a big step toward developing effective therapeutic treatments for bone skeletal defects, bone loss and osteoporosis.
Study shows prolonged stress sparks ER to release calcium stores and induce cell death in aging-related diseases such as atherosclerosis, diabetes and neurodegeneration
It should be possible to use therapeutic vaccines to create both cheap and effective drugs for diseases like cancer and allergies. One problem in developing such vaccines has previously been the lack of adjuvants, substances that make vaccines more effective. However, there has now been a major breakthrough in this area. The study, led by Swedish scientists at Uppsala University, is published in the December issue of the journal Vaccine.
A physician and researcher at the Sainte Justine University Hospital Center (Sainte-Justine UHC), a University of Montreal affiliate, saved the life of a child and, by doing so, became the first to find a new use for a drug in the fight against deadly E. coli bacteria.
Existing practice surrounding many cardiovascular medications, including anti-hypertensive and lipid-lowering agents, is based on the evaluation of response to therapy. In cases where ideal therapeutic targets (which have been identified through several previous studies) are not met in the single individual, there is evidence to support the need to intensify standard treatment so as to achieve better control of the cardiovascular risk factor under treatment (e.g. blood pressure or cholesterol levels) as this translates into a better outcome.
› Verified 2 days ago
Jennifer Aileen Rowley, FNP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 26 S Main St, Centerville, UT 84014 Phone: 801-693-7900 | |
Susanna Oley Smith, PMHNP-BC Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 190 S Main St Ste B, Centerville, UT 84014 Phone: 801-614-8400 | |
Emily Wilcox, DNP, APRN, PMHNP-BC Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 190 S Main St Ste B, Centerville, UT 84014 Phone: 801-614-8400 | |
Amanda D Webb-ellis, FNP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 392 N Main St, Centerville, UT 84014 Phone: 801-577-8678 |